Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
18.60
-1.49 (-7.42%)
At close: Apr 28, 2026, 4:00 PM EDT
18.25
-0.35 (-1.88%)
After-hours: Apr 28, 2026, 4:20 PM EDT
Aktis Oncology Market Cap
Aktis Oncology has a market cap or net worth of $1.03 billion as of April 28, 2026.
Market Cap
1.03B
Enterprise Value
812.89M
1-Year Change
n/a
Ranking
Category
Stock Price
$18.60
Market Cap Chart
Since the IPO on January 9, 2026, Aktis Oncology's market cap has increased from $945.40M to $1.03B, an increase of 8.75%. That is a compound annual growth rate of 32.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.11B | 17.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 1.26B |
| GH Research | 1.26B |
| MoonLake Immunotherapeutics | 1.23B |
| Jade Biosciences | 1.23B |
| DBV Technologies | 1.18B |
| Pharming Group | 1.17B |
| UroGen Pharma | 1.17B |
| EyePoint | 1.15B |